Growth Metrics

Teladoc Health (TDOC) Return on Equity (2016 - 2025)

Teladoc Health (TDOC) has disclosed Return on Equity for 11 consecutive years, with 0.14% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 52.0% to 0.14% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.14% through Dec 2025, up 52.0% year-over-year, with the annual reading at 0.14% for FY2025, 39.0% up from the prior year.
  • Return on Equity hit 0.14% in Q4 2025 for Teladoc Health, up from 0.16% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.01% in Q1 2021 to a low of 3.27% in Q4 2022.
  • Historically, Return on Equity has averaged 0.83% across 5 years, with a median of 0.54% in 2022.
  • Biggest five-year swings in Return on Equity: crashed -324bps in 2022 and later skyrocketed 317bps in 2023.
  • Year by year, Return on Equity stood at 0.03% in 2021, then plummeted by -12108bps to 3.27% in 2022, then soared by 97bps to 0.1% in 2023, then plummeted by -600bps to 0.67% in 2024, then soared by 78bps to 0.14% in 2025.
  • Business Quant data shows Return on Equity for TDOC at 0.14% in Q4 2025, 0.16% in Q3 2025, and 0.15% in Q2 2025.